Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 2 |
NetGPI | no | yes: 0, no: 2 |
Related structures:
AlphaFold database: Q4QEQ5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 128 | 132 | PF00656 | 0.667 |
CLV_C14_Caspase3-7 | 191 | 195 | PF00656 | 0.795 |
CLV_C14_Caspase3-7 | 76 | 80 | PF00656 | 0.634 |
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.672 |
CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.624 |
CLV_NRD_NRD_1 | 16 | 18 | PF00675 | 0.610 |
CLV_NRD_NRD_1 | 178 | 180 | PF00675 | 0.477 |
CLV_NRD_NRD_1 | 182 | 184 | PF00675 | 0.472 |
CLV_NRD_NRD_1 | 98 | 100 | PF00675 | 0.684 |
CLV_PCSK_FUR_1 | 14 | 18 | PF00082 | 0.660 |
CLV_PCSK_FUR_1 | 179 | 183 | PF00082 | 0.650 |
CLV_PCSK_FUR_1 | 96 | 100 | PF00082 | 0.665 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.672 |
CLV_PCSK_KEX2_1 | 115 | 117 | PF00082 | 0.603 |
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.610 |
CLV_PCSK_KEX2_1 | 178 | 180 | PF00082 | 0.477 |
CLV_PCSK_KEX2_1 | 181 | 183 | PF00082 | 0.494 |
CLV_PCSK_KEX2_1 | 232 | 234 | PF00082 | 0.649 |
CLV_PCSK_KEX2_1 | 96 | 98 | PF00082 | 0.662 |
CLV_PCSK_PC1ET2_1 | 181 | 183 | PF00082 | 0.674 |
CLV_PCSK_PC1ET2_1 | 232 | 234 | PF00082 | 0.649 |
CLV_PCSK_PC7_1 | 12 | 18 | PF00082 | 0.663 |
CLV_PCSK_PC7_1 | 178 | 184 | PF00082 | 0.649 |
CLV_PCSK_PC7_1 | 93 | 99 | PF00082 | 0.658 |
CLV_PCSK_SKI1_1 | 178 | 182 | PF00082 | 0.506 |
CLV_PCSK_SKI1_1 | 219 | 223 | PF00082 | 0.522 |
DOC_CDC14_PxL_1 | 59 | 67 | PF14671 | 0.618 |
DOC_CYCLIN_yCln2_LP_2 | 245 | 251 | PF00134 | 0.728 |
DOC_CYCLIN_yCln2_LP_2 | 60 | 66 | PF00134 | 0.621 |
DOC_MAPK_MEF2A_6 | 53 | 62 | PF00069 | 0.638 |
DOC_PP2B_LxvP_1 | 221 | 224 | PF13499 | 0.432 |
DOC_PP2B_LxvP_1 | 245 | 248 | PF13499 | 0.732 |
DOC_PP2B_LxvP_1 | 60 | 63 | PF13499 | 0.756 |
DOC_PP2B_LxvP_1 | 64 | 67 | PF13499 | 0.695 |
DOC_USP7_MATH_1 | 200 | 204 | PF00917 | 0.653 |
DOC_USP7_MATH_2 | 248 | 254 | PF00917 | 0.705 |
DOC_WW_Pin1_4 | 48 | 53 | PF00397 | 0.696 |
LIG_14-3-3_CanoR_1 | 31 | 39 | PF00244 | 0.723 |
LIG_APCC_ABBA_1 | 71 | 76 | PF00400 | 0.638 |
LIG_BIR_III_4 | 207 | 211 | PF00653 | 0.700 |
LIG_BRCT_BRCA1_1 | 147 | 151 | PF00533 | 0.607 |
LIG_eIF4E_1 | 171 | 177 | PF01652 | 0.602 |
LIG_FHA_1 | 234 | 240 | PF00498 | 0.672 |
LIG_FHA_1 | 31 | 37 | PF00498 | 0.621 |
LIG_FHA_2 | 191 | 197 | PF00498 | 0.793 |
LIG_LIR_Gen_1 | 148 | 159 | PF02991 | 0.593 |
LIG_LIR_Nem_3 | 148 | 154 | PF02991 | 0.594 |
LIG_LIR_Nem_3 | 240 | 245 | PF02991 | 0.551 |
LIG_MYND_1 | 63 | 67 | PF01753 | 0.624 |
LIG_Pex14_1 | 242 | 246 | PF04695 | 0.730 |
LIG_Pex14_2 | 151 | 155 | PF04695 | 0.580 |
LIG_SH2_SRC | 246 | 249 | PF00017 | 0.653 |
LIG_SH2_STAT5 | 156 | 159 | PF00017 | 0.599 |
LIG_SH2_STAT5 | 246 | 249 | PF00017 | 0.734 |
LIG_SH3_3 | 161 | 167 | PF00018 | 0.653 |
LIG_SH3_3 | 52 | 58 | PF00018 | 0.712 |
LIG_SUMO_SIM_anti_2 | 38 | 43 | PF11976 | 0.594 |
LIG_TYR_ITIM | 154 | 159 | PF00017 | 0.589 |
MOD_CDK_SPK_2 | 48 | 53 | PF00069 | 0.626 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.818 |
MOD_CK1_1 | 203 | 209 | PF00069 | 0.578 |
MOD_CK1_1 | 237 | 243 | PF00069 | 0.559 |
MOD_CK1_1 | 51 | 57 | PF00069 | 0.625 |
MOD_CK1_1 | 89 | 95 | PF00069 | 0.636 |
MOD_CK2_1 | 122 | 128 | PF00069 | 0.821 |
MOD_CK2_1 | 190 | 196 | PF00069 | 0.656 |
MOD_Cter_Amidation | 9 | 12 | PF01082 | 0.672 |
MOD_GlcNHglycan | 109 | 112 | PF01048 | 0.811 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.677 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.555 |
MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.478 |
MOD_GlcNHglycan | 186 | 189 | PF01048 | 0.602 |
MOD_GlcNHglycan | 190 | 193 | PF01048 | 0.623 |
MOD_GlcNHglycan | 198 | 201 | PF01048 | 0.582 |
MOD_GlcNHglycan | 252 | 255 | PF01048 | 0.684 |
MOD_GSK3_1 | 103 | 110 | PF00069 | 0.723 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.647 |
MOD_GSK3_1 | 184 | 191 | PF00069 | 0.759 |
MOD_GSK3_1 | 196 | 203 | PF00069 | 0.556 |
MOD_GSK3_1 | 233 | 240 | PF00069 | 0.669 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.743 |
MOD_LATS_1 | 113 | 119 | PF00433 | 0.812 |
MOD_NEK2_1 | 109 | 114 | PF00069 | 0.811 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.678 |
MOD_NEK2_1 | 35 | 40 | PF00069 | 0.738 |
MOD_NEK2_1 | 86 | 91 | PF00069 | 0.630 |
MOD_OFUCOSY | 157 | 162 | PF10250 | 0.621 |
MOD_PKA_1 | 115 | 121 | PF00069 | 0.814 |
MOD_PKA_2 | 10 | 16 | PF00069 | 0.663 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.814 |
MOD_PKA_2 | 30 | 36 | PF00069 | 0.505 |
MOD_Plk_1 | 145 | 151 | PF00069 | 0.445 |
MOD_Plk_1 | 234 | 240 | PF00069 | 0.672 |
MOD_Plk_4 | 150 | 156 | PF00069 | 0.590 |
MOD_Plk_4 | 172 | 178 | PF00069 | 0.601 |
MOD_Plk_4 | 37 | 43 | PF00069 | 0.594 |
MOD_Plk_4 | 44 | 50 | PF00069 | 0.541 |
MOD_ProDKin_1 | 48 | 54 | PF00069 | 0.696 |
TRG_DiLeu_BaLyEn_6 | 240 | 245 | PF01217 | 0.722 |
TRG_DiLeu_BaLyEn_6 | 55 | 60 | PF01217 | 0.537 |
TRG_ENDOCYTIC_2 | 156 | 159 | PF00928 | 0.599 |
TRG_ENDOCYTIC_2 | 171 | 174 | PF00928 | 0.611 |
TRG_ER_diArg_1 | 11 | 14 | PF00400 | 0.669 |
TRG_ER_diArg_1 | 114 | 116 | PF00400 | 0.604 |
TRG_ER_diArg_1 | 16 | 18 | PF00400 | 0.610 |
TRG_ER_diArg_1 | 177 | 179 | PF00400 | 0.623 |
TRG_ER_diArg_1 | 182 | 184 | PF00400 | 0.575 |
TRG_ER_diArg_1 | 95 | 98 | PF00400 | 0.658 |
TRG_NLS_MonoExtN_4 | 178 | 185 | PF00514 | 0.658 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
E9AQS2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 100% |